<?xml version="1.0" encoding="UTF-8"?>
<ref id="b59-ol-0-0-12525">
 <label>59</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ma</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>CC</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>LY</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>JJ</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>BS</given-names>
   </name>
   <name>
    <surname>Cai</surname>
    <given-names>HQ</given-names>
   </name>
   <name>
    <surname>Hao</surname>
    <given-names>JJ</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Cai</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>MR</given-names>
   </name>
  </person-group>
  <article-title>ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis</article-title>
  <source>J Exp Clin Cancer Res</source>
  <volume>37</volume>
  <fpage>183</fpage>
  <year>2018</year>
  <pub-id pub-id-type="doi">10.1186/s13046-018-0851-y</pub-id>
  <?supplied-pmid 30081903?>
  <pub-id pub-id-type="pmid">30081903</pub-id>
 </element-citation>
</ref>
